Advent Life Sciences
Investor profile
Deals
6
distinct rounds
Companies
6
backed
Active span
2020–2025
6 yrs
Total round €
€218M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Morningside Ventures2
- AdBio partners1
- BGF1
- Bioqube Ventures1
- Bpifrance1
- British Business Bank1
- British Patient Capital1
- Cambridge Innovation Capital1
- Cowen Healthcare Investments1
- CTI Life Sciences1
- Emerson Collective1
- EQT Life Sciences1
- Fonds de solidarité FTQ1
- Forbion1
- Harrington Discovery Institute1
- Minderoo Foundation1
- Mubadala Capital1
- Novateur Ventures1
- Novo Holdings1
- Sofinnova Partners1
- SoftBank1
- Swiss VC Pureos Bioventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Proximie | UK | 1 | €77M |
| F2G | UK | 1 | €69M |
| Cyted Health | UK | 1 | €38M |
| Tridek-One | France | 1 | €16M |
| Epitopea | UK | 1 | €12M |
| Amphista Therapeutics | UK | 1 | €6.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Proximie | Series C | €77M | 2022-06 |
| F2G | Other | €69M | 2022-08 |
| Cyted Health | Series B | €38M | 2025-09 |
| Tridek-One | Other | €16M | 2022-09 |
| Epitopea | Seed | €12M | 2022-04 |
| Amphista Therapeutics | Series A | €6.9M | 2020-07 |